Endovascular treatment for nonacute symptomatic portal venous thrombosis through intrahepatic portosystemic shunt approach

J Vasc Interv Radiol. 2011 Jan;22(1):61-9. doi: 10.1016/j.jvir.2010.07.028. Epub 2010 Nov 24.

Abstract

Purpose: To study the safety and efficacy of nonacute symptomatic portal vein thrombosis (PVT) treated by mechanical thrombectomy combined with pharmacologic thrombolysis through an intrahepatic portosystemic shunt (IPS) approach.

Materials and methods: Thirteen patients with nonacute symptomatic PVT were included in this study: five women and eight men, with a mean age of 48.9 y. Indications for therapy were variceal bleeding (n = 7) and abdominal pain, distension, or intermittent melena (n = 6). Through an IPS approach, balloon angioplasty, sheath-directed thrombus aspiration, and continuous infusion of urokinase were performed. Clinical follow-up was performed in all patients.

Results: An IPS was successfully created in all patients. After therapy, recanalization of all thrombosed main PVs was achieved. A majority of thrombus was removed and lysed. The overall rate of clinical improvement was 92.3%. One patient died of intraperitoneal bleeding the second day after the procedure, and another two patients experienced minor complications after therapy and recovered completely after conservative medical management. During a mean of 14.9 months of follow-up, two patients experienced recurrent variceal bleeding as a result of shunt dysfunction. Hemostasis was achieved after shunt revision. No other complications occurred.

Conclusions: Through an IPS approach, mechanical thrombectomy combined with pharmacologic thrombolysis was possible as a therapeutic option for patients with nonacute symptomatic PVT.

MeSH terms

  • Adult
  • Aged
  • Angioplasty, Balloon
  • China
  • Combined Modality Therapy
  • Endovascular Procedures* / adverse effects
  • Endovascular Procedures* / mortality
  • Female
  • Fibrinolytic Agents / administration & dosage
  • Humans
  • Male
  • Middle Aged
  • Portal Vein* / diagnostic imaging
  • Portasystemic Shunt, Surgical* / adverse effects
  • Portasystemic Shunt, Surgical* / mortality
  • Retrospective Studies
  • Suction
  • Thrombectomy
  • Thrombolytic Therapy
  • Time Factors
  • Tomography, X-Ray Computed
  • Treatment Outcome
  • Ultrasonography
  • Urokinase-Type Plasminogen Activator / administration & dosage
  • Venous Thrombosis / diagnosis
  • Venous Thrombosis / mortality
  • Venous Thrombosis / therapy*

Substances

  • Fibrinolytic Agents
  • Urokinase-Type Plasminogen Activator